Saturday, January 16, 2016 4:47:13 AM
In that small period of time they comercialy launched
- Hydromorphone Hydrochloride 8mg Tablets
- Naltrexone Hydrochloride 50 mg Tablets
- Phentermine HCl 37.5 mg Tablets
- Phentermine HCI 15 mg and 30 mg Capsules
- Isradipine 2,5 mg and 5 mg capsules
- Phendimetrazine Tartrate 35 mg Tablets, USP
- Dantrolene sodium 25 mg , 50 mg and 100 mg tablets
- Hydroxyzine HCI 10 mg, 25 mg, 50 mg Tablets
- Loxapine 5 mg , 10 mg , 25mg and 50 mg capsules
- 10 Additional Approved ANDA's
Selling their own branded product
- Lodrane D
And contract manufactoring
- Methadone Hydrochloride 10 mg Tablets
Working with different Companies to devellop new products
One based in Hong Kongt
Secured 15mil from ELI200 partner before even one pill is sold
Months away from beeing the first player in the +20 Billion abuse resistant/deterent opioid market
Competition years away
Phase 3 pivotal trial met its primary endpoint (p = 0.001), demonstrating statistical significance that the product provided pain relief following surgery in the treatment group using ELI-200 compared to the placebo group. Secondary endpoint results were consistent with primary findings and included safety measures.
Within few weeks FDA accepts filling for first ART product wich non abuse deterent variation had over $3 billion in sales wich will trigger the partner to send out an army of 100 salesman to educate about and sell ELI200 all over the countfry
Immagine what 200mil in revenue cn do for a company worth only 200 mil
And thats from only one product
They have whole line of 15 ART Product waiting to be filed with the FDA TO GARNER EVERY PENNY THEY CAN FROM THIS 20 BILLION DOLLAR MARKET
And from zero to of that happend in just over 3 year
So imo those new 7 year here new longs we never beore heard of calling this a pollished turd bought high , old low and looking to re enter even cheper
Recent ELTP News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/28/2024 09:23:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/23/2024 12:27:32 PM
- ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • InvestorsHub NewsWire • 10/23/2024 12:03:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 08:47:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/27/2024 08:30:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 09:16:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:05:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2024 08:07:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 08:30:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2024 09:55:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/29/2023 07:21:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/26/2023 09:20:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2023 12:05:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:58:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 11:50:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration with ZenaDrone • InvestorsHub NewsWire • 11/16/2023 12:32:07 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM